vs

Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and Inspire Medical Systems, Inc. (INSP). Click either name above to swap in a different company.

Inspire Medical Systems, Inc. is the larger business by last-quarter revenue ($204.6M vs $134.9M, roughly 1.5× CareTrust REIT, Inc.). On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs 1.6%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs 2.2%).

Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

Inspire Medical Systems, Inc. is a medical technology firm that develops, manufactures and commercializes implantable neurostimulation solutions for obstructive sleep apnea. Its core product serves patients intolerant to CPAP therapy, with main markets across North America, Europe, and select Asia-Pacific regions, operating in sleep medicine and otolaryngology segments.

CTRE vs INSP — Head-to-Head

Bigger by revenue
INSP
INSP
1.5× larger
INSP
$204.6M
$134.9M
CTRE
Growing faster (revenue YoY)
CTRE
CTRE
+53.5% gap
CTRE
55.1%
1.6%
INSP
Faster 2-yr revenue CAGR
CTRE
CTRE
Annualised
CTRE
46.2%
2.2%
INSP

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CTRE
CTRE
INSP
INSP
Revenue
$134.9M
$204.6M
Net Profit
$111.3M
Gross Margin
86.5%
Operating Margin
13.0%
Net Margin
82.5%
Revenue YoY
55.1%
1.6%
Net Profit YoY
113.5%
EPS (diluted)
$0.52
$-0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTRE
CTRE
INSP
INSP
Q1 26
$204.6M
Q4 25
$134.9M
$269.1M
Q3 25
$132.4M
$224.5M
Q2 25
$112.5M
$217.1M
Q1 25
$96.6M
$201.3M
Q4 24
$86.9M
$239.7M
Q3 24
$77.4M
$203.2M
Q2 24
$68.9M
$195.9M
Net Profit
CTRE
CTRE
INSP
INSP
Q1 26
Q4 25
$111.3M
$136.1M
Q3 25
$74.9M
$9.9M
Q2 25
$68.5M
$-3.6M
Q1 25
$65.8M
$3.0M
Q4 24
$52.1M
$35.2M
Q3 24
$33.4M
$18.5M
Q2 24
$10.8M
$9.8M
Gross Margin
CTRE
CTRE
INSP
INSP
Q1 26
86.5%
Q4 25
86.6%
Q3 25
85.8%
Q2 25
84.0%
Q1 25
84.7%
Q4 24
85.0%
Q3 24
84.1%
Q2 24
84.8%
Operating Margin
CTRE
CTRE
INSP
INSP
Q1 26
13.0%
Q4 25
17.1%
Q3 25
58.1%
4.3%
Q2 25
61.3%
-1.5%
Q1 25
-0.7%
Q4 24
13.3%
Q3 24
43.0%
7.0%
Q2 24
15.1%
2.6%
Net Margin
CTRE
CTRE
INSP
INSP
Q1 26
Q4 25
82.5%
50.6%
Q3 25
56.6%
4.4%
Q2 25
60.9%
-1.7%
Q1 25
68.1%
1.5%
Q4 24
60.0%
14.7%
Q3 24
43.2%
9.1%
Q2 24
15.6%
5.0%
EPS (diluted)
CTRE
CTRE
INSP
INSP
Q1 26
$-0.39
Q4 25
$0.52
$4.57
Q3 25
$0.35
$0.34
Q2 25
$0.35
$-0.12
Q1 25
$0.35
$0.10
Q4 24
$0.30
$1.17
Q3 24
$0.21
$0.60
Q2 24
$0.07
$0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTRE
CTRE
INSP
INSP
Cash + ST InvestmentsLiquidity on hand
$198.0M
$98.9M
Total DebtLower is stronger
$894.2M
Stockholders' EquityBook value
$4.0B
$792.3M
Total Assets
$5.1B
$911.4M
Debt / EquityLower = less leverage
0.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTRE
CTRE
INSP
INSP
Q1 26
$98.9M
Q4 25
$198.0M
$308.3M
Q3 25
$712.5M
$322.6M
Q2 25
$306.1M
$300.9M
Q1 25
$26.5M
$369.2M
Q4 24
$213.8M
$445.5M
Q3 24
$377.1M
$411.0M
Q2 24
$495.1M
$439.7M
Total Debt
CTRE
CTRE
INSP
INSP
Q1 26
Q4 25
$894.2M
Q3 25
$893.8M
Q2 25
$1.2B
Q1 25
$822.1M
Q4 24
$396.9M
Q3 24
$396.7M
Q2 24
$671.1M
Stockholders' Equity
CTRE
CTRE
INSP
INSP
Q1 26
$792.3M
Q4 25
$4.0B
$781.2M
Q3 25
$4.0B
$666.5M
Q2 25
$3.3B
$677.8M
Q1 25
$2.9B
$635.7M
Q4 24
$2.9B
$689.7M
Q3 24
$2.4B
$696.6M
Q2 24
$1.9B
$638.1M
Total Assets
CTRE
CTRE
INSP
INSP
Q1 26
$911.4M
Q4 25
$5.1B
$907.3M
Q3 25
$5.1B
$807.7M
Q2 25
$4.7B
$802.2M
Q1 25
$3.9B
$730.8M
Q4 24
$3.4B
$808.4M
Q3 24
$2.9B
$796.2M
Q2 24
$2.7B
$728.4M
Debt / Equity
CTRE
CTRE
INSP
INSP
Q1 26
Q4 25
0.22×
Q3 25
0.22×
Q2 25
0.35×
Q1 25
0.28×
Q4 24
0.14×
Q3 24
0.16×
Q2 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTRE
CTRE
INSP
INSP
Operating Cash FlowLast quarter
$394.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.54×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTRE
CTRE
INSP
INSP
Q1 26
Q4 25
$394.0M
$52.5M
Q3 25
$100.9M
$68.5M
Q2 25
$100.8M
$2.7M
Q1 25
$71.4M
$-6.7M
Q4 24
$244.3M
$69.2M
Q3 24
$67.2M
$52.3M
Q2 24
$53.0M
$-78.0K
Free Cash Flow
CTRE
CTRE
INSP
INSP
Q1 26
Q4 25
$41.8M
Q3 25
$58.1M
Q2 25
$-6.3M
Q1 25
$-15.1M
Q4 24
$62.2M
Q3 24
$44.3M
Q2 24
$-12.5M
FCF Margin
CTRE
CTRE
INSP
INSP
Q1 26
Q4 25
15.5%
Q3 25
25.9%
Q2 25
-2.9%
Q1 25
-7.5%
Q4 24
25.9%
Q3 24
21.8%
Q2 24
-6.4%
Capex Intensity
CTRE
CTRE
INSP
INSP
Q1 26
Q4 25
4.0%
Q3 25
4.6%
Q2 25
4.1%
Q1 25
4.2%
Q4 24
2.9%
Q3 24
3.9%
Q2 24
6.3%
Cash Conversion
CTRE
CTRE
INSP
INSP
Q1 26
Q4 25
3.54×
0.39×
Q3 25
1.35×
6.90×
Q2 25
1.47×
Q1 25
1.08×
-2.24×
Q4 24
4.68×
1.96×
Q3 24
2.01×
2.83×
Q2 24
4.92×
-0.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons